4//SEC Filing
Blumenkranz Mark S. 4
Accession 0001415889-24-016569
CIK 0001479419other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 8:00 PM ET
Size
10.2 KB
Accession
0001415889-24-016569
Insider Transaction Report
Form 4
KALA BIO, Inc.KALA
Blumenkranz Mark S.
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-11+3,150→ 3,150 totalExercise: $6.18Exp: 2034-06-10→ Common Stock (3,150 underlying) - Award
Common Stock
2024-06-11+1,400→ 13,091 total
Holdings
- 168,454(indirect: See footnote)
Common Stock
- 1,276(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service, the RSUs will vest as to 100% of the shares underlying the grant on the earlier of (i) June 11, 2025 or (ii) the date of the first annual meeting following June 11, 2024.
- [F2]Includes 6,615 unvested RSUs.
- [F3]These securities are held directly by Lagunita Biosciences, LLC ("Lagunita"). The reporting person is a managing partner of Lagunita and may be deemed to have beneficial ownership over the Lagunita Shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F4]These securities are held directly by Garland Investments, L.P. ("Garland"). The reporting person is a managing partner of Garland and may be deemed to have beneficial ownership over the Garland Shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F5]This option was granted on June 11, 2024 and vests as to 100% of the shares underlying the grant on the earlier of (i) June 11, 2025 or (ii) the date of the first annual meeting following June 11, 2024.
Documents
Issuer
KALA BIO, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001614869
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 8:00 PM ET
- Size
- 10.2 KB